ClinicalTrials.Veeva

Menu

Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

C

Catholic University (KU) of Leuven

Status

Completed

Conditions

Inflammatory Bowel Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT01666717
ML4355_VOC

Details and patient eligibility

About

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).

Enrollment

204 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of IBD
  • Age >18 years

Exclusion criteria

  • Use of antibiotics in the preceding month
  • Intake of pre- or probiotics

Trial design

204 participants in 2 patient groups

Healthy controls (HC)
Description:
HC
Inflammatory Bowel Disease (IBD) patients
Description:
Crohn's disease (CD), Ulcerative colitis (UC) and pouchitis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems